Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a new Locations section listing participating sites across Arizona, California, Colorado, Florida, Kansas, Maryland, Minnesota, Missouri, Nebraska, New York, North Carolina, Pennsylvania, Texas, and Utah; updated the page revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T21:32:28.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added study record update dates 2025-12-16 and 2025-12-13, and removed dates 2025-12-09 and 2025-12-06 from the Study Record Dates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-16T20:27:19.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    New update dates were added (2025-12-09, 2026-01-06, 2025-12-06, 2025-12) and older timestamps removed, with no substantive changes to the study details.
    Difference
    0.2%
    Check dated 2025-12-09T16:58:34.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added explicit primary and secondary objectives for the Phase I/II trial, including maximum tolerated combination safety and MRI-based objective response rate, and extended follow-up timing (treatment start to at least two years) with associated imaging and biomarker assessments. Also clarified or updated study procedures (MRI, blood sample collection, echocardiography) and removed certain earlier timepoint references such as 'Up to 100 days'.
    Difference
    0.5%
    Check dated 2025-12-02T16:25:40.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated to v3.3.2; previous v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T13:32:05.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The only change is the removal of a general government funding status notice; there are no edits to core study information, eligibility criteria, or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:18:04.000Z thumbnail image

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.